Utilization of Perioperative Intravesical Chemotherapy During Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy
Urol. Oncol 2022 Aug 04;[EPub Ahead of Print], AP Kenigsberg, G Carpinito, SA Gold, X Meng, A Ghoreifi, H Djaladat, A Minervini, M Jamil, F Abdollah, JM Farrow, C Sundaram, R Uzzo, M Ferro, M Meagher, I Derweesh, Z Wu, J Porter, A Katims, R Mehrazin, A Mottrie, G Simone, AC Reese, DD Eun, AS Bhattu, ML Gonzalgo, U Carbonara, R Autorino, V MargulisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.